Therapeutic effects of acivicin and N-(phosphonacetyl)-L-aspartic acid in a biochemically designed trial against a N-(phosphonacetyl)-L-aspartic acid-resistant variant of the Lewis lung carcinoma. [electronic resource]
Producer: 19810421Description: 905-9 p. digitalISSN:- 0008-5472
- Animals
- Aspartate Carbamoyltransferase -- antagonists & inhibitors
- Aspartic Acid -- administration & dosage
- Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) -- antagonists & inhibitors
- Carcinoma -- drug therapy
- Drug Therapy, Combination
- Glycine -- administration & dosage
- Isoxazoles -- administration & dosage
- Ligases -- antagonists & inhibitors
- Lung Neoplasms -- drug therapy
- Neoplasms, Experimental -- drug therapy
- Organophosphorus Compounds -- administration & dosage
- Oxazoles -- administration & dosage
- Phosphonoacetic Acid -- administration & dosage
- Pyrimidines -- biosynthesis
- Rats
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.